Stratrix
On the Record · Indivior Pharmaceuticals

Indivior Pharmaceuticals subsidiaries, as it lists them

The subsidiaries Indivior Pharmaceuticals lists in its latest annual report, with the jurisdiction of each, linked to the filing.

Subsidiaries it lists

SubsidiaryJurisdiction
Indivior LimitedEngland and Wales
Indivior Canada LtdCanada
Indivior Deutschland GmbHGermany
Indivior España S.L.U.Spain
Indivior EU LimitedEngland and Wales
Indivior Europe LimitedIreland
Indivior Finance LLCDelaware (US)
Indivior Finance (2014) LLCDelaware (US)
Indivior France SASFrance
Indivior Global Holdings LimitedEngland and Wales
Indivior Inc.Delaware (US)
Indivior Israel LtdIsrael
Indivior Italia S.r.lItaly
Indivior Jersey Finance LLCDelaware (US)
Indivior Jersey Finance (2021) LimitedJersey
Indivior Manufacturing LLCDelaware (US)
Indivior Nordics ApSDenmark
Indivior Pty LtdAustralia
Indivior Schweiz AGSwitzerland
Indivior SMTM LLCDelaware (US)
Indivior Solutions Inc.Delaware (US)
Indivior South Africa (Pty) LtdSouth Africa
Indivior Treatment Services, Inc.Delaware (US)
Indivior UK LimitedEngland and Wales
Indivior UK Finance No1 LimitedEngland and Wales
Indivior UK Finance No2 LimitedEngland and Wales
Indivior UK Finance No3 LimitedEngland and Wales
Indivior US Holdings Inc.Delaware (US)
Indy 1 (UK) LimitedEngland and Wales
Opiant Pharmaceuticals UK LimitedEngland and Wales
RBP Global Holdings LimitedEngland and Wales

From Exhibit 21 of the 10-K for 2025. Companies must list their significant subsidiaries there and may leave out smaller ones, so this is the company’s own list, not every entity it owns.

Read from Indivior Pharmaceuticals’s annual reports (10-K for 2025, 10-K for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-02-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.